|
ZNF79 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.836200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.614800E-04 |
| Normal-vs-Stage2 |
3.649600E-01 |
| Normal-vs-Stage3 |
5.594800E-01 |
| Normal-vs-Stage4 |
5.592000E-01 |
| Stage1-vs-Stage2 |
8.967700E-02 |
| Stage1-vs-Stage3 |
2.40799999999819E-05 |
| Stage1-vs-Stage4 |
2.161900E-04 |
| Stage2-vs-Stage3 |
1.742440E-01 |
| Stage2-vs-Stage4 |
1.920390E-01 |
| Stage3-vs-Stage4 |
9.456000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.563980E-01 |
| Normal-vs-AfricanAmerican |
1.047950E-01 |
| Normal-vs-Asian |
4.006000E-04 |
| Caucasian-vs-AfricanAmerican |
3.276800E-01 |
| Caucasian-vs-Asian |
6.318800E-03 |
| AfricanAmerican-vs-Asian |
5.137900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.735200E-01 |
| Normal-vs-Female |
6.881200E-03 |
| Male-vs-Female |
1.232230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.844400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.515800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.417400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.672000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.281800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.721400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.301000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.513590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.093600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.302400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.775980E-04 |
| Normal-vs-Grade 2 |
4.064900E-03 |
| Normal-vs-Grade 3 |
5.981400E-01 |
| Normal-vs-Grade 4 |
5.082000E-01 |
| Grade 1-vs-Grade 2 |
3.225800E-02 |
| Grade 1-vs-Grade 3 |
2.021600E-03 |
| Grade 1-vs-Grade 4 |
1.200470E-03 |
| Grade 2-vs-Grade 3 |
4.443000E-03 |
| Grade 2-vs-Grade 4 |
1.201610E-03 |
| Grade 3-vs-Grade 4 |
2.294000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.231200E-04 |
| Normal-vs-ccB subtype |
6.881800E-01 |
| ccA subtype-vs-ccB subtype |
5.174900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.866610E-01 |
| Normal-vs-N1 |
7.278800E-01 |
| N0-vs-N1 |
3.870200E-01 |
|
|
